AdaptHealth (AHCO) Net Equity Issued and Repurchased (2021)

AdaptHealth's (AHCO) quarterly Net Equity Issued and Repurchased came in at $278.8 million in Q1 2021.

AdaptHealth (AHCO) Net Equity Issued and Repurchased (2021) Analysis & Trends

AdaptHealth's Net Equity Issued and Repurchased history runs 1 years deep, the most recent figure standing at $278.8 million for Q1 2021.

  • On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $278.8 million in Q1 2021; TTM through Dec 2021 was $278.8 million, a N/A change from a year earlier, with the FY2021 full-year figure at $278.8 million, up 95.55% from the prior year.
  • Net Equity Issued and Repurchased was little changed at $278.8 million in Q1 2021 per AHCO's latest filing.
  • Across five years, Net Equity Issued and Repurchased topped out at $278.8 million in Q1 2021 and bottomed at $278.8 million in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Abbott Laboratories 182.32 Bn 175.03 Bn 6.27 Bn -
2 Stryker 128.82 Bn 125.95 Bn 3.81 Bn -
3 Medtronic 108.46 Bn 99.24 Bn 6.41 Bn 97.00 Mn
4 Boston Scientific 68.25 Bn 66.79 Bn 3.61 Bn -
5 Edwards Lifesciences 47.64 Bn 43.97 Bn 1.29 Bn -
6 Dexcom 28.55 Bn 27.43 Bn 750.30 Mn 12.70 Mn
7 GE HealthCare Technologies 28.51 Bn 26.22 Bn 1.98 Bn -
8 Smith & Nephew 26.96 Bn 26.39 Bn - -
9 Koninklijke Philips 25.42 Bn 22.29 Bn 2.07 Bn -
10 AdaptHealth 1.49 Bn 1.44 Bn 111.50 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2021 278.85 Mn
Mar 31, 2021 278.85 Mn